Human vascular adhesion proteın-1 (VAP-1): Serum levels for hepatocellular carcinoma in non-alcoholic and alcoholic fatty liver disease

World Journal of Surgical Oncology

Volumn 8, Issue , 2010, Pages

  Kemik, Ozgur ^a   Sümer, Aziz ^a   Kemik, Ahu S ^b   Itik, Veyis ^a   Dulger, Ahmet C ^a   Purisa, Sevim ^b   Tuzun, Sefa ^c  

^a YUZUNCU YIL UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

^c Haseki Educational Research Hospital   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULAR ADHESION PROTEIN 1; AMINE OXIDASE (COPPER CONTAINING); AOC3 PROTEIN, HUMAN; CELL ADHESION MOLECULE; SIALOGLYCOPROTEIN; TUMOR MARKER;

ADULT; ARTICLE; CANCER PATIENT; DISEASE MARKER; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; PROTEIN BLOOD LEVEL; BLOOD; COMPARATIVE STUDY; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FATTY LIVER; FOLLOW UP; LIVER TUMOR; MIDDLE AGED; PROGNOSIS;

AMINE OXIDASE (COPPER-CONTAINING); CARCINOMA, HEPATOCELLULAR; CELL ADHESION MOLECULES; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FATTY LIVER; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; SIALOGLYCOPROTEINS; TUMOR MARKERS, BIOLOGICAL;

EID: 77957340031     PISSN: None     EISSN: 14777819     Source Type: Journal    
DOI: 10.1186/1477-7819-8-83     Document Type: Article

References (22)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001, 91:153-6.
2. Bosch FX, Ribes J, Diaz M, Cleries R. Primary liver cancer: worldwide incidence and trends. Gastroenterology 2004, 127:S5-S16. 10.1053/j.gastro.2004.09.011, 15508102.
3. Salmi M, Jalkanen S. A 90-kilodalton endothelial cell molecule mediating lymphocyte binding in humans. Science 1992, 257:1407-9. 10.1126/science.1529341, 1529341.
4. Salmi M, Tohka S, Berg EL, Butcher EC, Jalkanen S. VAP-1 mediates lymphocyte subtype-specific, selectin-independent recognition of vascular endothelium in human lymph nodes. J Exp Med 1997, 186:589-600. 10.1084/jem.186.4.589, 2199032, 9254657.
5. Salmi M, Kalimo K, Jalkanen S. Induction and function of vascular adhesion protein-1 at sites of inflammation. J Exp Med 1993, 178:2255-60. 10.1084/jem.178.6.2255, 2191278, 8245796.
6. McNab G, Reeves JL, Salmi M, Hubscher S, Jalkanen S, Adams DH. Vascular adhesion protein 1 mediates binding of T cells to human hepatic endothelium. Gastroenterology 1996, 110:522-8. 10.1053/gast.1996.v110.pm8566600, 8566600.
7. Salmi M, Jalkanen S. Human vascular endothelial adhesion protein 1 (VAP-1) is a unique sialoglycoprotein that mediates carbohydrate-dependent binding of lymphocytes to endothelial cells. J Exp Med 1996, 183:569-79. 10.1084/jem.183.2.569, 2192471, 8627168.
8. Smith D, Salmi M, Bono P, Hellman J, Leu T, Jalkanen S. Cloning of vascular adhesion protein-1 reveals a novel multifunctional adhesion molecule. J Exp Med 1998, 188:17-27. 10.1084/jem.188.1.17, 2525535, 9653080.
9. Gearing AJH, Hemingway IK, Pigott R, Hughes J, Rees AJ, Cashman SJ. Soluble forms of vascular adhesion molecules, E-Selectin, ICAM-1 and VCAM-1:pathological significance. Ann NY Acad Sci 1992, 667:324-31. 10.1111/j.1749-6632.1992.tb51633.x, 1285023.
10. Goldberger A, Middleton KA, Oliver JA, Paddock C, Yan HC, Albelda SM, Delisser HM, Newman PJ. Biosynthesis and processing of the cell adhesion molecule PECAM-1 includes production of a soluble form. J Biol Chem 1994, 269:17183-91.
11. Dunlop LC, Skinner MP, Bendall J, Favaloro J, Castaldi PA, Gorman JJ, Gamble JR, Vadas MA, Berndt MC. Characterization of GMP-140 (P-Selectin) as a circulating plasma protein. J Exp Med 1992, 175:1147-50. 10.1084/jem.175.4.1147, 2119167, 1372646.
12. Newman W, Beall LD, Carson CW, Hunder GG, Graben N, Randhawa ZI, Gopal TV, Wiener-Kronish J, Matthay MA. Soluble E-selectin is found in supernatants of activated endothelial cells and s elevated in the serum of patients with septic shock. J Immunol 1993, 150:644-54.
13. Bazil V. Physiological enzymatic cleavage of leukocyte membrane molecules. Immunol Today 1995, 16:135-40. 10.1016/0167-5699(95)80130-8, 7718086.
14. Meyer DM, Dustin ML, Carron CP. Characterization of intercellular adhesion molecule-1 ectodomain as an inhibitor of lymphocyte function-associated molecule-1 interaction with ICAM-1. J Immunol 1995, 155:3578-84.
15. Hwang ST, Singer MS, Giblin PA, Yednock TA, Bacon KB, Simon SI, Rosen SD. GlyCAM-1, a physiologic ligand for L-selectin, activates β 2 integrins on naïve peripheral lymphocytes. J Exp Med 1996, 184:1343-8. 10.1084/jem.184.4.1343, 2192819, 8879206.
16. Gearing AJ, Newman W. Circulating adhesion molecule in disease. Immunol Today 1993, 10:506-12.
17. Ristamäki R, Joensuu H, Salmi M, Jalkanen S. Serum CD44 in malignant lymphoma: an association with treatment response. Blood 1994, 84:238-43.
18. Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, Christensen E, Pagliaro L, Colombo M, Rodés J. EASL Panel of Experts on HCC. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 2001, 3:421-430.
19. Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR. Nonalcoholic steatohepatitis: a proposal for gradine and staging the histological lesions. Am J Gastroenterol 1999, 94:2467-74. 10.1111/j.1572-0241.1999.01377.x, 10484010.
20. Kurkijärvi R, Adams DH, Leino R, Möttönen T, Jalkanen S, Salmi M. Circulating form of human vascular adhesion protein-1:Increased serum levels in inflammatory liver diseases. The J Immunol 1998, 161:1549-57.
21. Wilson JF. Liver cancer on the rise. Ann Intern Med 2005, 142:1029-32.
22. Toiyama Y, Miki C, Inoue Y, Kawamoto A, Kusunoki M. Circulating form of human vascular adhesion protein-1 (VAP-1): decreased serum levels in progression of colorectal cancer and predictive marker of lymphatic and hepatic metastasis. J Surg Oncol 2009, 99:368-372. 10.1002/jso.21246, 19204971.